Chester County News and Community Website
PHILADELPHIA, PA — Vittoria Biotherapeutics, Inc. has announced the launch of its Phase 1 clinical trial for VIPER-101, a cutting-edge gene-edited cell therapy aimed at treating relapsed and refractory (r/r) T …
Vittoria Biotherapeutics Launches Trial for Innovative T Cell Lymphoma Therapy Read More PHILADELPHIA, PA — Vittoria Biotherapeutics will present groundbreaking research on its innovative Senza5™ platform at the 66th American Society of Hematology (ASH) Annual Meeting in San Diego, CA, from December …
Vittoria Biotherapeutics Showcases Advancements in T Cell Therapies at 66th ASH Annual Meeting Read More PHILADELPHIA, PA — Vittoria Biotherapeutics announced a significant publication by University of Pennsylvania investigators in Science Immunology. The paper highlights the role of CD5, an immunomodulatory protein, in enhancing engineered …
Vittoria Biotherapeutics’ Senza5 Platform Featured in Science Immunology Read More